MTNB logo

MTNB Shareholders Equity

Annual Shareholders Equity

$19.25 M
-$17.39 M-47.47%

December 31, 2023


Summary


Performance

MTNB Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMTNBbalance sheetmetrics:

Quarterly Shareholders Equity

$15.78 M
-$3.32 M-17.40%

September 30, 2024


Summary


Performance

MTNB Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMTNBbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

MTNB Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-47.5%-31.8%
3 y3 years-69.8%-31.8%
5 y5 years+19.2%-31.8%

MTNB Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-63.3%at low-69.9%+8.4%
5 y5-year-69.8%at low-79.7%+8.4%
alltimeall time-69.8%+763.9%-79.7%+608.3%

Matinas BioPharma Holdings Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$15.78 M(-17.4%)
Jun 2024
-
$19.10 M(+31.2%)
Mar 2024
-
$14.56 M(-24.4%)
Dec 2023
$19.25 M(-47.5%)
$19.25 M(-16.9%)
Sep 2023
-
$23.15 M(-16.9%)
Jun 2023
-
$27.85 M(-14.6%)
Mar 2023
-
$32.63 M(-11.0%)
Dec 2022
$36.64 M(-30.2%)
$36.64 M(-5.1%)
Sep 2022
-
$38.62 M(-9.9%)
Jun 2022
-
$42.85 M(-10.1%)
Mar 2022
-
$47.68 M(-9.2%)
Dec 2021
$52.49 M(-17.6%)
$52.49 M(-9.9%)
Sep 2021
-
$58.25 M(-7.4%)
Jun 2021
-
$62.90 M(-5.5%)
Mar 2021
-
$66.56 M(+4.4%)
Dec 2020
$63.73 M(+92.8%)
$63.73 M(-6.6%)
Sep 2020
-
$68.21 M(-6.3%)
Jun 2020
-
$72.82 M(-6.2%)
Mar 2020
-
$77.60 M(+134.8%)
Dec 2019
$33.05 M
$33.05 M(-13.0%)
Sep 2019
-
$37.98 M(-6.0%)
Jun 2019
-
$40.42 M(-6.0%)
DateAnnualQuarterly
Mar 2019
-
$43.01 M(+166.4%)
Dec 2018
$16.14 M(+51.1%)
$16.14 M(+56.7%)
Sep 2018
-
$10.30 M(-17.8%)
Jun 2018
-
$12.53 M(+48.5%)
Mar 2018
-
$8.43 M(-21.0%)
Dec 2017
$10.68 M(+49.4%)
$10.68 M(-16.4%)
Sep 2017
-
$12.78 M(-15.9%)
Jun 2017
-
$15.21 M(-19.4%)
Mar 2017
-
$18.86 M(+163.8%)
Dec 2016
$7.15 M(+17.7%)
$7.15 M(-18.0%)
Sep 2016
-
$8.72 M(+191.0%)
Jun 2016
-
$3.00 M(-29.0%)
Mar 2016
-
$4.22 M(-30.5%)
Dec 2015
$6.07 M(+172.6%)
$6.07 M(-12.8%)
Sep 2015
-
$6.96 M(-19.3%)
Jun 2015
-
$8.63 M(+35.0%)
Mar 2015
-
$6.39 M(+186.9%)
Dec 2014
$2.23 M(-78.7%)
$2.23 M(-53.1%)
Sep 2014
-
$4.75 M(-26.5%)
Jun 2014
-
$6.46 M(-25.0%)
Mar 2014
-
$8.61 M(-17.8%)
Dec 2013
$10.47 M
$10.47 M

FAQ

  • What is Matinas BioPharma Holdings annual stockholders equity?
  • What is the all time high annual shareholders equity for Matinas BioPharma Holdings?
  • What is Matinas BioPharma Holdings annual shareholders equity year-on-year change?
  • What is Matinas BioPharma Holdings quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Matinas BioPharma Holdings?
  • What is Matinas BioPharma Holdings quarterly shareholders equity year-on-year change?

What is Matinas BioPharma Holdings annual stockholders equity?

The current annual shareholders equity of MTNB is $19.25 M

What is the all time high annual shareholders equity for Matinas BioPharma Holdings?

Matinas BioPharma Holdings all-time high annual stockholders equity is $63.73 M

What is Matinas BioPharma Holdings annual shareholders equity year-on-year change?

Over the past year, MTNB annual stockholders equity has changed by -$17.39 M (-47.47%)

What is Matinas BioPharma Holdings quarterly stockholders equity?

The current quarterly shareholders equity of MTNB is $15.78 M

What is the all time high quarterly shareholders equity for Matinas BioPharma Holdings?

Matinas BioPharma Holdings all-time high quarterly stockholders equity is $77.60 M

What is Matinas BioPharma Holdings quarterly shareholders equity year-on-year change?

Over the past year, MTNB quarterly stockholders equity has changed by -$7.37 M (-31.84%)